Vaxxinova aims at providing a full range of both autogenous (where allowed) and licensed vaccines (where registered) combined with high-level diagnostic services, supported by our strong R&D. Our focus is on production animals including poultry, aqua, cattle and swine.

Though Vaxxinova was officially named and founded in 2010, our predecessors have been in the production animal vaccine and diagnostics business since the 1950s. Vaxxinova can rely on more than 6 decades of expertise in disease prevention for production animals and our products and services are available in more than 75 countries.

Our current technology network comprises production, research & development and diagnostic facilities in 10 countries: Brazil, Chile, Italy, Germany, Japan, Jordan, Norway, Thailand, the USA and the Netherlands.

a